| SpectraBase Spectrum ID |
GULmaD6H9do |
| Name |
N2-(3-Methoxybenzyl)-5-methoxytryptamine |
| Classification |
Tryptamine designer drug |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
310.168127954 u |
| Formula |
C19H22N2O2 |
| InChI |
InChI=1S/C19H22N2O2/c1-22-16-5-3-4-14(10-16)12-20-9-8-15-13-21-19-7-6-17(23-2)11-18(15)19/h3-7,10-11,13,20-21H,8-9,12H2,1-2H3 |
| InChIKey |
CJLDIVRTIQMENX-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
310.397 g/mol |
| Nominal Mass |
310 u |
| Quality |
999 |
| Retention Index |
2903 |
| SMILES |
C=12C(NC=C2CCNCC=2C=C(C=CC2)OC)=CC=C(C1)OC |
| SPLASH |
splash10-03k9-1900000000-4a9fecf4022b62419f77 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
5-MeO Tryptamine NB3OMe
N2-(meta-Methoxybenzyl)-5-methoxytryptamine
2-(5-Methoxy-1H-indol-3-yl)-N-(3-methoxybenzyl)ethan-1-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_020055 |
